What Happens in the Body During GLP-1 Treatment
The cysteine-rich and glycosylated regions of DPP-4 carry out the non-enzymatic functions, involved in cell signaling, immune regulation, inflammation, and tissue remodeling (Zhong et al., 2013)
Various other techniques have been developed that offer potential advantages over the standard approach
The topical route is the format with the strongest human clinical trial evidence for skin outcomes, from the landmark 1998 Abdulghani study that outperformed both vitamin C and tretinoin to the Finkley skin-thickness data
The skin barrier physically prevents most weight-loss compounds (including berberine at therapeutic doses) from being absorbed in useful amounts
Ozempic, a star GLP-1, steps onto the scene as a type 2 diabetes medication, preparing for its starring role in the SUSTAIN trials